Health & Biotech ASX Health Stocks: Acrux jumps 70pc after launching its acne gel in the US April 3, 2024 Acrux announced launch of acne gel in the US. Recce Pharma granted Israeli patent for its anti-infectives R327 and R529. Anteris Technologies is leading a heart condition treatment revolution April 3, 2024 Anteris Technologies (ASX:AVR) has developed the world’s first, single piece transcatheter aortic valve called the DurAVR THV. Medtech Optiscan beefs up operations in US, hires two high-level execs April 2, 2024 Optiscan is beefing up its presence in the US as it works toward securing US regulatory approvals for its confocal… ASX Health Stocks: NSB jumps 30pc after disclosing upcoming meeting with US FDA April 2, 2024 Neuroscientific Biopharma to have a pre-IND meeting with US FDA. The NSB stock price jumped as high as 30pc this… Melodiol’s Mernova gains more traction in Canada: revenues increase, new products launched April 2, 2024 Melodiol Global Health Limited (ASX:ME1)’s wholly-owned Canadian subsidiary, Mernova, has continued its gain traction on the back of strong demand… MGC Pharmaceuticals rebrands as Argent BioPharma in strategic transformation April 2, 2024 MGC Pharmaceuticals has officially rebranded and restructure as Argent BioPharma in the culmination of an extensive capital and operational restructuring,… ASX Health Stocks: Argenica jumps 20pc on Phase 2 update, Fisher&Paykel could lose $12m from recall March 28, 2024 Argenica jumps after announcing first patient dosing. Fisher & Paykel sets aside $12m after voluntary recall. Aroa Biosurgery targets sales growth and operations cash flow positivity in FY25 March 28, 2024 Aroa Biosurgery (ASX:ARX) is focused on achieving operations cashflow positive in FY25 as its US distribution partner reports strong growth. Melodiol subsidiaries contribute $3.1 million revenue in first two months of 2024 March 27, 2024 Melodiol Global Health has generated unaudited revenue of $3.1 million in the first two months of FY24 with its wholly-owned… Race Oncology achieves ‘major milestone’ in progress of lead drug to human trials March 27, 2024 Race Oncology has been issued a Certificate of Analysis (CoA) for its first current Good Manufacturing Practice (cGMP) batch of… Next» « Previous